Propofol (2.6 diisopropylphenol), a non-barbiturate anaesthetic agent in an emulsion formulation, provides a smooth induction of anaesthesia without major adverse effect, and is associated with rapid clear-headed recovery (Cummings et al., 1984; Nightingale et al., 1984; Kay and Healy, 1985; MacKenzie and Grant, 1985) . A previous study in non-intubated patients showed that the administration of propofol was associated with a significant decrease in intraocular pressure (IOP) (Mirakhur and Shepherd, 1985) . In the present study, we have compared the effects of propofol on IOP with those of thiopentone in patients receving suxamethonium, and in whom tracheal intubation was performed.
Propofol (2.6 diisopropylphenol), a non-barbiturate anaesthetic agent in an emulsion formulation, provides a smooth induction of anaesthesia without major adverse effect, and is associated with rapid clear-headed recovery (Cummings et al., 1984; Nightingale et al., 1984; Kay and Healy, 1985; MacKenzie and Grant, 1985) . A previous study in non-intubated patients showed that the administration of propofol was associated with a significant decrease in intraocular pressure (IOP) (Mirakhur and Shepherd, 1985) . In the present study, we have compared the effects of propofol on IOP with those of thiopentone in patients receving suxamethonium, and in whom tracheal intubation was performed.
PATIENTS AND METHODS
Sixty adult patients, 16-83 years old, conforming to ASA grades I and II and scheduled to undergo elective ophthalmic surgery, were included in the study after obtaining the approval of the Hospital Ethical Committee, and the informed consent of the patients. Patients with pre-existing increases in IOP (glaucoma), hypertension, obesity (body weight greater than 120 % of that expected for age) or those receiving any drugs likely to have an effect on IOP were excluded. Following premedication with diazepam 5-10 mg by mouth, 30 patients each received a dose of either propofol 2.0-2.5 mg kg~l or thiopentone 4.5-5.0 mg kg" sufficient to induce sleep-as judged by the loss of eyelash reflex and failure to respond to verbal communication. This was followed by suxamethonium 1.0 mg kg" 1 and the trachea was intubated 2 min later. Half the patients in each group received an additional smaller dose of the same induction agent (propofol 1.0 mg kg" 1 or thiopentone intubation.
SUMMARY
2.0 mg kg" 1 ) immediately before IOP was measured using a hand-held applanation tonometer (Perkins, 1965) in the eye not to be operated upon. Baseline (control) values of IOP were obtained before the induction of anaesthesia following instillation of 1 % amethocaine. Further measurements of IOP were made after the administration of the propofol or the thiopentone, 1 and 2 min after the administration of the suxamethonium, and 1,2 and 3 min after the intubation of the trachea. Heart rate and arterial pressure were measured and recorded at the same times using anECGandanoscillometer(Dinamap), respectively. Note was also made of any pain on injection or any other side effects such as involuntary movements, tremor, hiccups etc. Based on these criteria, the induction of anaesthesia was classified as good, adequate or poordepending on the observation of no, minor or severe side effects, respectively.
Analysis of variance was applied at each time point to determine the significance of the changes in IOP, arterial pressure and heart rate. When the overall F ratio was statistically significant, pairs of means were compared using Student's t test.
RESULTS
The patients in the four subgroups were comparable with regard to age, weight and IOP (table  I ). This table also shows that the average induction doses were 2.1 mg kg" 1 for propofol and 4.9 mg kg" 1 for thiopentone. The average induction time was around 40 s, and in the majority the induction agent was injected to a vein on the dorsum of the hand. Values of IOP in the various groups are given in table II, with percentage changes shown in figure 1. The administration of the induction agent produced a significant (P < 0.0005) decrease in IOP which averaged around 40% with propofol and 31% with thiopentone: the differences were not significant between the groups. The administration of suxamethonium produced an increase in IOP in all groups, the increase being slightly less in those given propofol, in whom the IOP remained less than baseline values in comparison with those receiving thiopentone. The absolute values of IOP were not significantly higher than baseline in any group, although the increase was significant (P < 0.001) when compared with the values obtained immediately before the administration of the suxamethonium in all groups. The administration of the second, smaller dose of the induction agent resulted in a decrease in IOP to about 27 % below baseline in those given propofol (P < 0.001), and by about 8% in those given thiopentone. Tracheal intubation produced the greatest increase in IOP, averaging about 25% above baseline in all groups except that given the additional dose of propofol, in whom the IOP was significantly lower (P < 0.05-0.001) in comparison with all the other groups. IOP in the two-dose propofol group always remained less than baseline; the increases were significant (P < 0.01) in the other three groups. Heart rates and systolic arterial pressures are given in tables III and IV. Although the administration of thiopentone tended to increase the heart rate slightly more than propofol, there were no significant differences in absolute heart rate amongst the groups, except in those given the second dose of induction agent, where patients given thiopentone showed a higher heart rate. Systolic arterial pressure decreased signifi-
TABLE III. Heart rate (beat min ') during induction and intubation (mcan±SD). Differences are significant between: (a) Propofol two doses v. thiopentone two doses at 2 min after suxamethonium (P < 0.05). (6) Propofol one dose v. thiopentone two doses before intubation (P < 0.01). (c) Propofol two doses v. thiopentone two doses after administration of the second dose of induction agents (P < 0.01). (d) Thiopentone one dose v.
thiopentone two doses before intubation (P < 0.05) Baseline (control) After induction agent 1 min after suxamethonium 2 min after suxamethonium After 2nd dose of induction agent 1 min after intubation 2 min after intubation 3 min after intubation candy (P < 0.01) soon after the induction of anaesthesia. The systolic pressures were significantly lower (P < 0.05-0.005) in those given propofol immediately before and 3 min after intubation. The administration of the second dose of propofol did not result in any further decrease in the average systolic arterial pressure. The average peak heart rates and arterial pressures following intubation were lower in those given propofol, but the differences were not significant. The incidence of side effects is given in table V. Ten (33 %) patients given propofol complained of modest to severe pain on injection. In most, the drug had been injected to a vein on the back of the hand. Forty percent of patients given propofol showed a decrease in systolic pressure of greater than 30% in comparison with 10% of those given thiopentone. This required the administration of 500-1000 ml of lactated Ringer's solution to four patients given propofol. Other side effects were mostly minor in nature. There was no difference in the overall quality of induction in the various groups, nor were there any venous sequelae up to 24 h after injection-although the veins were not solely used for the administration of the induction agents.
DISCUSSION
The findings from the present study confirm the results of previous investigations that the induction of anaesthesia with propofol or thiopentone is associated with useful and significant decreases in IOP, with propofol producing a marginally greater effect (Joshi and Bruce, 1975; Mirakhur and Shepherd, 1985) . The present study was, however, designed to assess the effects of these agents on IOP in the face of two factors, the administration of suxamethonium and tracheal intubation, known to produce increases in IOP (Pandey, Badola and Kumar, 1972) . It is clear that the stimulus of intubation produces an increase in IOP which is even greater than that observed after the administration of suxamethonium. In spite of an initial decrease, the administration of suxamethonium and intubation of the trachea increased the IOP above the control values in three out of the four groups, the increase being greater in those patients in whom anaesthesia was induced with thiopentone. However, IOP always remained below baseline values when the induction dose of propofol was followed by a smaller second dose of propofol immediately before intubation. The rationale for administering a second dose of the induction agent before intubation was based on the observation that this technique helps to attenuate the increase in intracranial pressure associated with intubation (Unni et al., 1984) , and it is known that the pressures in the eye and in the central nervous system are affected similarly by a number of factors. The usefulness of this technique using propofol is further shown by the observation of a rapid decrease in IOP once the stimulating effects of intubation had abated. The lack of protective effect of the second smaller dose of thiopentone is surprising, but may be related to the fact that the administration of thiopentone did not cause such a marked decrease in IOP before intubation. It may also be a result of the fact that propofol, particularly the second dose, produces a deeper and smoother sleep. Part of the beneficial effect on IOP may also be attributable to a greater reduction in systolic arterial pressure seen with this agent.
Other factors such as central venous pressure or carbon dioxide tensions in arterial blood could have affected the results (Hvidberg, Kessing and Fernandes, 1981; Smith, Aass and Nemoto, 1981) However, all patients were horizontal throughout the period of study and ventilation was assisted or controlled as soon as indicated using a nonrebreathing circuit. Moreover, all groups would be similarly affected and, in addition, this was designed to simulate as closely as possible the routine induction of anaesthesia.
It is true that the use of a non-depolarizing neuromuscular blocking drug would not have increased the IOP after the induction of anaesthesia, but suxamethonium was used as a challenge to assess both the effects of propofol and the usefulness of a second smaller dose of induction agent before intubation. Moreover, it is likely that intubation, which is essential in all intraocular surgery, would have produced an increase in IOP anyway. We are, however, studying this technique using non-depolarizing neuromuscular blocking drugs.
Although other side effects of propofol are generally minimal, significant and clinically important hypotension occurs frequently. This is a limitation to its use, particularly in elderly patients. Thus it should be used with discretion, or perhaps avoided, when a decrease in arterial pressure would be particularly undesirable. However, hypotension responded to simple treatment such as the infusion of 500-1000 ml of lactated Ringer's solution.
In conclusion, propofol appears to be a suitable agent with which to induce anaesthesia in ophthalmic surgical patients, particularly if an additional small dose is given immediately before intubation.
